Prescriptions indicators | (n = 50 prescriptions) | |||
Pre-test | Post-Test | |||
Frequency | Per cent | Frequency | Per cent | |
Prescriptions where antimalarial drug adequately labelled | 17 | 34.0% | 24 | 48.0% |
Prescriptions where antimalarial drug not adequately labelled | 33 | 66.0% | 26 | 52.0% |
Total | 50 | 100.0% | 50 | 100.0% |
Antimalarial drug regimens prescribed as 1st line treatment of uncomplicated/Severe MIPs | Pre-test | Post-Test | ||
Frequency | Per cent | Frequency | Per cent | |
Artemether+lumefantrine ALU (Coartem) | 31 | 62.0% | 39 | 78.0% |
Oral Quinine | 9 | 18.0% | 3 | 6.0% |
Parenteral Quinine | 1 | 2.0% | 4 | 8.0% |
Artemether injectable | 7 | 14.0% | 2 | 4.0% |
Parenteral Artesunate | 2 | 4.0% | 2 | 4.0% |
Total | 50 | 100.0% | 50 | 100.0% |
Prescription pattern for Antimalarial drug prescribed combined with other drugs and Antimalarial drug prescribed injection form | Pre-test | Post-Test | ||
Frequency | Per cent | Frequency | Per cent | |
Antimalarial drug injection form | 10 | 20.0% | 9 | 18.0% |
Antimalarial + antibiotic | 9 | 18.0% | 7 | 14.0% |
Anti-malarial + Iron & folic acid tablets | 31 | 62.0% | 34 | 68.0% |
Total | 50 | 100.0% | 50 | 100.0% |